Use of Furosemide and Chlorothiazide Combination Continuous Infusion in Furosemide-Refractory Patients in the Pediatric Intensive Care Unit: A Retrospective Cohort Study.
Journal
Paediatric drugs
ISSN: 1179-2019
Titre abrégé: Paediatr Drugs
Pays: Switzerland
ID NLM: 100883685
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
accepted:
07
09
2021
pubmed:
12
10
2021
medline:
26
11
2021
entrez:
11
10
2021
Statut:
ppublish
Résumé
Our objective was to describe the efficacy and safety of furosemide and chlorothiazide combination continuous infusion (FCCCI) in children in a pediatric intensive care unit (ICU), including postoperative cardiac patients. This was a retrospective cohort study in a pediatric ICU within a tertiary care teaching hospital. Children aged < 18 years admitted from 1 January 2010 to 31 December 2019 were included if they received a furosemide infusion for at least 6 h and then transitioned to FCCCI. Each patient acted as their own control. A total of 203 patients (107 [53%] postoperative cardiac) met the study inclusion criteria. The study population was 55% male and 74% Caucasian, with a median age of 4.9 months. Of the total patients, 143 (70.4%) required mechanical ventilation and 39 (19.2%) required dialysis. The median duration of furosemide and FCCCI was 24.6 h (interquartile range [IQR] 12.4-54) and 41 h (IQR 15-162), respectively. Urine output increased by 52% with FCCCI (mean increase of 2.2 mL/kg/h [95% confidence interval {CI} 1.8-2.5]; p < 0.01). The change to FCCCI led to a net negative daily fluid balance (mean difference - 301.9 mL/day [95% CI - 390.9 to - 212.9]; p < 0.01). FCCCI resulted in a greater requirement for potassium bolus supplementation (mean increase of 12.8 boluses [95% CI 8.5-17.2]; p < 0.01) and a small but statistically significant increase in serum creatinine (mean difference 0.1 mg/dL [95% CI 0.06-0.14]; p < 0.01) with a resultant decrease in estimated glomerular filtration rate (mean difference - 13.5 [95% CI 9.7-17.4]; p < 0.01). Of the furosemide-refractory patients, 78.9% were responsive to FCCCI. Younger patients and patients who underwent cardiothoracic surgery were more likely to be responsive. Nonresponders to FCCCI had slightly higher mortality (21 vs. 6.6%, p = 0.05). FCCCI resulted in a significant improvement in diuresis with achievement of negative fluid balance in pediatric ICU patients. FCCCI is a reasonable approach to aggressive diuresis in the pediatric patient, particularly in patients with limited access. Serum potassium should be routinely monitored during such therapy.
Identifiants
pubmed: 34632558
doi: 10.1007/s40272-021-00472-0
pii: 10.1007/s40272-021-00472-0
doi:
Substances chimiques
Diuretics
0
Chlorothiazide
77W477J15H
Furosemide
7LXU5N7ZO5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
575-582Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.
doi: 10.1007/s00134-012-2769-8
Sinitsky L, Walls D, Nadel S, et al. Fluid overload at 48 hours is associated with respiratory morbidity but not mortality in a general PICU: retrospective cohort study. Pediatr Crit Care Med. 2015;16(3):205–9.
doi: 10.1097/PCC.0000000000000318
Malbrain ML, Marik PE, Witters I, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361–80.
doi: 10.5603/AIT.2014.0060
Carpenter RJ, Kouyoumjian S, Moromisato DY, et al. Lower-dose, intravenous chlorothiazide is an effective adjunct diuretic to furosemide following pediatric cardiac surgery. J Pediatr Pharmacol Ther. 2020;25(1):31–8.
pubmed: 31897073
pmcid: 6938290
Jentzer JC, DeWald TA, Hernandez AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol. 2010;56(19):1527–34.
doi: 10.1016/j.jacc.2010.06.034
Congenital Heart Surgery Public Reporting [Internet]. Chicago (IL): The Society of Thoracic Surgeons. 2021. https://publicreporting.sts.org/chsd-exp . Accessed 13 Mar 2021.
McIntosh AM, Tong S, Deakyne SJ, et al. Validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med. 2017;18(8):750–7.
doi: 10.1097/PCC.0000000000001191
Schwartz GJ, Haycock GB, Edelmann CM Jr, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259–63.
pubmed: 951142
Sutherland SM, Byrnes JJ, Kothari M, et al. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol. 2015;10(4):554–61.
doi: 10.2215/CJN.01900214
2020 ASP Drug Pricing Files [Internet]. Baltimore (MD): Centers for Medicare & Medicaid Services. 2020. https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/2020-asp-drug-pricing-files . Accessed 13 Mar 2021.
Klinge J, Scharf J, Hofbeck M, et al. Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. Intensive Care Med. 1997;23(6):693–7.
doi: 10.1007/s001340050395
Singh N, Kissoon N, Bennett M, et al. Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients. Crit Care Med. 1992;20(1):17–21.
doi: 10.1097/00003246-199201000-00010
Moffett BS, Tsang R, Kennedy C, et al. Efficacy of sequential nephron blockade with intravenous chlorothiazide to promote diuresis in cardiac intensive care infants. Cardiol Young. 2017;27(6):1104–9.
doi: 10.1017/S1047951116002122
Cies JJ, Moore WS, Chopra A, et al. Stability of furosemide and chlorothiazide stored in syringes. Am J Health Sys Pharm. 2015;72(24):2182–8.
doi: 10.2146/ajhp150023
Thomas CA, Morris JL, Sinclair EA, et al. Implementation of a diuretic stewardship program in a pediatric cardiovascular intensive care unit to reduce medication expenditures. Am J Health Sys Pharm. 2015;72(12):1047–105.
doi: 10.2146/ajhp140532